|
| Clinical research on treating thrombotic cerebral infarction with atherosclerosis (Qi deficiency and blood stasis syndrome) with mailoutong |
| Hits 1903 Download times 2045 Received:March 01, 2010 |
| View Full Text View/Add Comment Download reader |
| DOI
10.11656/j.issn.1673-9043.2010.02.08 |
| Key Words
Mailuotong;atherosclerosis;thrombotic cerebral infarction;Qi deficiency and blood stasis syndrome;clinical trial |
| Author Name | Affiliation | | HU Ben-song | Tianjin University of TCM, Tianjin 300193, China | | LI Yan | 天津中医药大学第一附属医院 300193 | | DAI Xiao-yu | 天津中医药大学第一附属医院 300193 |
|
| Abstract
|
| [Objective] To evaluate the effect and safety of Mailuotong in treating atherosclerotic thrombosis of cerebral infarction with Qi deficiency and blood stasis syndrome.[Methods] The clinical research was done with random,positive-medicine paralleled and non-inferiority trial.[Results] There was no significant difference between treatment group and control group.The total effective rate of treatment group was 71.4% while that of control group was 69.3%.The non-inferiority trial on the total effective rate of these two groups established and had a consistent conclusion of FAS and PPS analysis.The 51.5% patients of treatment group and 43.2% patients of control group improved their life quality after treating for 28 days and the scores for daily life abilities increased by 11.8 and 9.35.There was no significant difference and no adverse reaction.[Conclusion] Mailuotong has a better effect in treating atherosclerotic thrombosis of cerebral infarction with Qi deficiency and blood stasis syndrome,compared with the clinical commonly used capsule of Buchang Zhongfeng Huichun capsule. |
|
